Swiss National Bank
RXST icon

Swiss National Bank’s RxSight RXST Stock Holding History

Swiss National Bank’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-66,300
Closed -$862K – 2358
2025
Q2 		$862K Hold
66,300
– – ﹤0.01% 2189
2025
Q1 		$1.67M Hold
66,300
– – ﹤0.01% 1872
2024
Q4 		$2.28M Buy
66,300
+1,700
+3% +$76.7K ﹤0.01% 1772
2024
Q3 		$3.19M Buy
64,600
+10,000
+18% +$512K ﹤0.01% 1583
2024
Q2 		$3.29M Buy
54,600
+1,500
+3% +$85.7K ﹤0.01% 1537
2024
Q1 		$2.74M Buy
53,100
+7,400
+16% +$363K ﹤0.01% 1663
2023
Q4 		$1.84M Buy
45,700
+1,300
+3% +$38.1K ﹤0.01% 1894
2023
Q3 		$1.24M Hold
44,400
– – ﹤0.01% 2120
2023
Q2 		$1.28M Buy
+44,400
New +$988K ﹤0.01% 2168

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Swiss National Bank's RXST Position: Q3 2025 in Review

Swiss National Bank sold out of RxSight (RXST) in Q3 2025, closing a stake of 66,300 shares — an estimated $862K sold.

Swiss National Bank first reported a position in RXST in Q2 2023 and held it in 9 quarters. The position peaked at $3.29M in Q2 2024. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

  • Swiss National Bank reported no remaining RxSight position as of Q3 2025 after selling out during the quarter.
  • Swiss National Bank sold 66,300 RxSight shares in Q3 2025, an estimated $862K.
  • Swiss National Bank first reported a position in RxSight in Q2 2023 and held it in 9 quarters.
  • Swiss National Bank's RxSight position peaked at $3.29M in Q2 2024.
  • 160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on Swiss National Bank's 13F filing for Q3 2025, filed 13 Nov 2025.